🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Westlate Chemical shares 'current valuation fair' says RBC Capital

EditorEmilio Ghigini
Published 14/06/2024, 11:56
WLK
-

On Friday, RBC Capital maintained a Sector Perform rating on Westlake Chemical Corporation (NYSE:WLK) with a steady price target of $158.00 for the shares. The firm's outlook suggests that the current performance of Westlake's High-Performance Polymers (HIP) segment is adequately factored into the market expectations for the years 2024 and 2025.

The analyst from RBC Capital noted that the robust performance of the HIP segment has balanced the recent softness in the Performance Ethylene Materials (PEM) segment. Despite these dynamics, the firm has decided to keep its financial forecasts for fiscal years 2024 and 2025 unchanged.

The guidance reflects the anticipation that the HIP segment will continue to grow at a mid-single-digit percentage rate or higher. This growth is expected to be driven by a combination of increasing market share and the expansion of Westlake's customer base.

The current valuation of Westlake Chemical's stock is considered fair by RBC Capital, as it trades at approximately 8 to 9 times the projected earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2024 and 2025. This valuation led to the reaffirmation of the Sector Perform rating, indicating that the stock is trading at a price that reflects its expected market performance.

Westlake Chemical, a manufacturer and supplier of petrochemicals, polymers, and building products, has seen its HIP segment grow due to the multiplier effect of securing more business with its expanding customer base. This performance has been a key factor in the company's ability to navigate through periods of weaker performance in other segments.

RBC Capital's assessment implies that the investment firm views Westlake Chemical's current stock price as aligned with its future financial performance, without signaling a significant undervaluation or overvaluation at this time.

In other recent news, Westlake Chemical has been making significant strides in its financial performance. The company's first-quarter 2024 earnings release showed net sales of $3 billion, EBITDA at $546 million, and net income of $174 million. The Housing and Infrastructure Products (HIP) segment particularly stood out, reporting a 14% increase in sales volume year-over-year.

Citi has raised the price target for Westlake Chemical shares to $168, up from $162, citing potential increases in EBITDA margins for the fiscal year 2024. The company's robust order volume positions it towards the upper end of the sales and margin guidance.

In addition, Piper Sandler has raised the stock price target for Westlake Chemical to $180 from the previous $160, reflecting confidence in the company's growth potential. Despite challenges in the product margins for PVC and epoxy, the firm expects improvements as the global economy recovers.

These recent developments highlight Westlake Chemical's financial health and the positive outlook from analysts. The company anticipates 2024 revenue for the HIP segment to be between $4 billion and $4.4 billion with an EBITDA margin of around 20%. It has also filed petitions to address low-priced Asian imports, aiming to bolster competitiveness.

InvestingPro Insights

Westlake Chemical Corporation (NYSE:WLK) presents an intriguing picture for investors, with a blend of financial metrics that could shape its market performance. As of the last twelve months as of Q1 2024, the company's market capitalization stands at a robust $19.7 billion, reflecting investor confidence. The adjusted P/E ratio has seen a significant shift to 34.26, which could be indicative of changing market perceptions regarding the company's earnings potential. Notably, the company's revenue has reached $12.17 billion, although it experienced a decline of 19.39% during the same period, which investors should consider when assessing the company's growth trajectory.

Two InvestingPro Tips highlight areas for potential attention: Firstly, the PEG Ratio is negative at -0.89, suggesting that the market may be anticipating slower growth relative to the company's earnings. Secondly, the Price to Book ratio is 1.91, which could appeal to value-oriented investors seeking assets that are reasonably priced relative to their book value. For those looking to delve deeper, InvestingPro offers additional tips on how to interpret these metrics in the context of Westlake's sector and historical performance. With the current coupon code PRONEWS24, investors can gain an additional 10% off a yearly or biyearly Pro and Pro+ subscription, which includes 7 more InvestingPro Tips to further inform investment decisions.

Overall, these data points and insights provide a richer context to RBC Capital's Sector Perform rating and price target for Westlake Chemical, offering investors a more nuanced understanding of the company's current standing and potential future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.